Continuing Education for Pharmacists: Staying Current on Generics

Pharmacists don’t just fill prescriptions-they make critical decisions every day that affect patient safety. One of the most high-stakes areas? generics. With 90% of all prescriptions filled with generic drugs in the U.S., and new generic approvals rising 17% year over year, staying current isn’t optional-it’s essential. Yet, many pharmacists still struggle with the complexity of therapeutic equivalence, state substitution laws, and the ever-changing FDA Orange Book. Continuing education (CPE) is the only way to keep up.

Why Generics Training Isn’t Just Another CE Requirement

It’s easy to think of continuing education as a box to check. But when you’re the one deciding whether to substitute a brand-name drug with a generic, the stakes are life or death. A 2021 ACPE report found that 42.7% of all pharmacy malpractice claims involved errors related to generic substitution. That’s not a small number. It’s a warning.

Take levothyroxine, for example. Even tiny differences in bioequivalence can cause serious harm. A patient switching between generic versions without proper oversight could end up with symptoms of hyper- or hypothyroidism. The FDA requires generics to be within 80-125% of the brand’s pharmacokinetic levels, but that range still leaves room for error if you don’t know which products are truly interchangeable. The Orange Book doesn’t just list generics-it assigns therapeutic equivalence ratings (AB, BX, etc.). Misreading one letter can lead to a dangerous substitution.

What’s Actually Required-State by State

Every state sets its own rules. In Illinois, pharmacists need 30 hours of CE every two years, including 1 hour each on sexual harassment prevention, implicit bias, and-starting January 2025-cultural competency. But here’s the catch: none of those hours are required to be about generics. That’s up to you.

Texas demands extra training on narrow therapeutic index (NTI) drugs like warfarin and phenytoin. California requires you to keep CE records for two years. New York wants certificates submitted with your renewal. And if you’re licensed in multiple states? You’re juggling different deadlines, different hour counts, and different topics.

The National Association of Boards of Pharmacy (NABP) found that only 5.2 hours of the average 27.5 hours pharmacists spend on CE each year are focused on generics and therapeutics. That’s less than one full day. For a field where the rules change monthly, it’s not enough.

ACPE Standards and What They Mean for You

All accredited continuing education must be approved by ACPE, the national body that sets the bar. ACPE divides CPE into three types: knowledge-based (lectures), application-based (case studies), and certificate programs (with hands-on assessments).

Here’s the truth: knowledge-based courses-where you watch a video and take a quiz-don’t stick. Pharmacists who took application-based courses with real patient cases reported 37% fewer substitution errors, according to the American Pharmacists Association (APhA). Why? Because you’re not memorizing facts-you’re practicing decisions.

Look for modules that walk you through actual scenarios: a patient on a stable dose of generic metoprolol suddenly develops fatigue. Is it the new generic? The manufacturer changed the filler. That’s not in the Orange Book. But it’s in the real world. That’s what you need to learn.

The FDA Orange Book: Your Daily Reference

The FDA Orange Book isn’t a dusty handbook. It’s a living document updated every month. It lists over 1,200 therapeutic equivalence ratings-and those ratings change. A drug rated AB one month might be BX the next if the manufacturer changes its formulation.

Pharmacists who don’t check the Orange Book before substituting are gambling. And the stakes? Patient outcomes. A 2023 study showed that pharmacists who reviewed the Orange Book weekly made 52% fewer substitution errors than those who checked it only quarterly.

Don’t rely on memory. Bookmark the FDA’s online version. Set up alerts for new generic approvals. Use apps like PocketPrep or Pharmacist’s Letter that sync with the Orange Book and flag changes in real time.

Biosimilars Are the Next Big Challenge

Biosimilars aren’t traditional generics. They’re complex biological products-like insulin or monoclonal antibodies-that mimic brand-name biologics. The FDA has different rules for them. Interchangeability isn’t automatic. Only 14 biosimilars have been approved as interchangeable as of late 2025, and even then, state laws vary on whether pharmacists can substitute them without prescriber approval.

A 2023 ASHP survey found that 78% of hospital pharmacists felt unprepared to handle biosimilar substitutions. That’s not because they’re unskilled-it’s because most CE courses still treat biosimilars as an afterthought.

Starting January 1, 2025, ACPE will require all generics-focused CE to include specific content on biosimilar interchangeability and REMS programs. If your current CE provider hasn’t updated their curriculum, they’re falling behind.

What Works-Real Stories from the Front Lines

One pharmacist in Chicago told me she caught a dangerous substitution because of a CE module she took six months earlier. A patient came in with a new prescription for a generic levothyroxine from a manufacturer she’d never seen before. She checked the Orange Book. The product was rated BX-meaning it wasn’t interchangeable with her patient’s current version. She called the prescriber. The original brand was reinstated. No harm done.

Another pharmacist in Texas said he used to skip CE courses on NTI drugs. Then his patient had a seizure after switching to a new generic phenytoin. The pharmacy had assumed all generics were equal. The CE course he took after that-focused on bioequivalence thresholds and formulation differences-changed how he practices.

These aren’t rare cases. They’re the norm.

How to Build a Real Generics Learning Plan

You don’t need to take 10 courses a year. But you do need a plan.

• Start with your state’s requirements. Know exactly what’s mandatory.
• Choose at least one application-based CE course per year focused on generics. Look for case studies, not lectures.
• Set a monthly reminder to check the FDA Orange Book for new generic approvals and rating changes.
• Join a peer group or online forum (like r/pharmacy on Reddit) to discuss real cases. You’ll learn more from a colleague’s mistake than from any textbook.
• Ask your employer for access to enterprise CE platforms. Hospitals and chains like CVS are investing in just-in-time learning tools that push updates to your phone when a new generic hits the shelves.

The Future Is Personalized

The old model-take a 2-hour webinar once a year-is broken. The next generation of CE will be smart. AI-powered platforms like those being piloted by IQVIA will analyze your prescription history, your state’s laws, and your past CE choices to recommend exactly what you need to know next.

Imagine this: You refill a prescription for a generic anticoagulant. Your pharmacy system pops up a 90-second video explaining why the new batch has a different inactive ingredient-and why it matters. No extra time. No extra cost. Just the right info, at the right moment.

That’s not science fiction. It’s coming by 2027.

Don’t Wait for a Mistake to Wake You Up

Generics are cheaper. They’re necessary. But they’re not simple. The system depends on you to get it right. Every time you substitute, you’re making a clinical judgment. And if you’re not keeping up, you’re risking lives.

You don’t need to be an expert in every generic on the market. But you do need to know how to find the answers-and when to pause before dispensing.

Start today. Pick one course. Check the Orange Book. Talk to a colleague. Your patients are counting on you.